Drug company Roche made a rare foray into the markets recently, with BNP Paribas being among the bookrunners putting together its record-breaking euro bond deal to finance the purchase of US biotech firm Genentech. Writer Edward Russell-Walling

Left to right: Christoph Seibel, Frederic Zorzi and Rupert Lewis

Left to right: Christoph Seibel, Frederic Zorzi and Rupert Lewis

PLEASE ENTER YOUR DETAILS TO WATCH THIS VIDEO

All fields are mandatory

The Banker is a service from the Financial Times. The Financial Times Ltd takes your privacy seriously.

Choose how you want us to contact you.

Invites and Offers from The Banker

Receive exclusive personalised event invitations, carefully curated offers and promotions from The Banker



For more information about how we use your data, please refer to our privacy and cookie policies.

Terms and conditions

Join our community

The Banker on Twitter